Andrew Tiu

MedStar Georgetown University Hospital — United States

Medicine · Health Sciences

12h-index315citations55works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Myeloproliferative Neoplasms: Diagnosis and Treatment(9), Ion Transport and Channel Regulation(6), Receptor Mechanisms and Signaling(5), Hormonal Regulation and Hypertension(5), Multiple Myeloma Research and Treatments(4)

Publications55 total

Prognostic Impact of Pre-Transplant Measurable Residual Disease in Acute Myeloid Leukemia: A Bayesian Meta-Analysis of Contemporary Allogeneic Hematopoietic Cell Transplantation Cohorts
Transplantation and Cellular Therapy·2026
Risk of myeloproliferative neoplasms among <scp>U.S.</scp> Veterans from Korean, Vietnam, and Persian Gulf War eras
American Journal of Hematology·2024· 2 citedOpen Access
Patient reported outcomes among U.S. Veterans living with myeloproliferative neoplasms.
Journal of Clinical Oncology·2024
Abstract TP224: Timing of Ischemic and Hemorrhagic Stroke With Myeloproliferative Neoplasm Diagnosis Among Veterans
Stroke·2024
Abstract WP249: Risk for Ischemic and Hemorrhagic Stroke is Increased in Veterans Exposed to Agent Orange and Those With Myeloproliferative Neoplasms
Stroke·2024· 1 cited
Evaluating the Association between Routine Pneumococcal Vaccination and COVID-19 Severity among Older Adults in the United States
2023· 1 citedOpen Access
Thrombosis and Bleeding Outcomes Among Veterans with Chronic Myeloid Leukemia and Association with Agent Orange Exposure
Blood·2023Open Access
Timing of Thrombosis with Myeloproliferative Neoplasm Diagnosis Among Veterans and Civilians
Blood·2023Open Access
Clinical Characteristics and Outcomes of Unusual Venous Thrombosis Sites Among Veterans with Myeloproliferative Neoplasms
Blood·2023· 1 cited
Cardiovascular Outcomes Among Myeloproliferative Neoplasm Patients with or without Agent Orange Exposure Using a Large Veteran Database
Blood·2023
HTRS2023.P4.20 Systematic review of global hemostasis assays in myeloproliferative neoplasms: promising tools for biomarkers for hypercoagulability
Research and Practice in Thrombosis and Haemostasis·2023Open Access
Association of Agent Orange and myeloproliferative neoplasms, thrombosis, and bleeding among veterans.
Journal of Clinical Oncology·2023
The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges
Seminars in Thrombosis and Hemostasis·2023· 3 cited
Agent Orange Exposure Enhances the Increased Risk of Cardiovascular Disease in Veterans with Myeloproliferative Neoplasms
SSRN Electronic Journal·2023Open Access
Global Hemostatic Assays for Risk Stratification of Thrombosis in Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis
Blood·2022
Multiple myeloma with central nervous system relapse presenting as right pupil‐sparing complete third nerve palsy
American Journal of Hematology·2022· 1 cited
Characterizing the Spatiotemporal Heterogeneity of the COVID-19 Vaccination Landscape
American Journal of Epidemiology·2022· 36 citedOpen Access
Sorting nexins: role in the regulation of blood pressure
FEBS Journal·2021· 8 citedOpen Access
Poorly differentiated urothelial carcinoma of the bladder and the impact of plasmacytoid variant
European Urology Open Science·2021Open Access
Characterizing the spatiotemporal heterogeneity of the COVID-19 vaccination landscape
2021· 19 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Craig M. Kessler(10), Pedro A. José(9), Kamolyut Lapumnuaypol(9), Shanshan Liu(9), Puneet Gill(9), Guoqing Diao(9), Minish Jain(9), Van Anthony M. Villar(8), Laureano D. Asico(8), Zoe McKinnell(8), Ramesh Subrahmanyam(8), Charat Thongprayoon(6), Karn Wijarnpreecha(6), Wisit Cheungpasitporn(6), Djeneba Audrey Djibo(5), Claudia Dourado(5), Martha Antonio(5), Shweta Bansal(4), Xiaoyan Wang(4), Sorab Gupta(4)